Apex Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GNC
GNC Holdings, Inc.
GNC
|
+$36.4M |
| 2 |
Ionis Pharmaceuticals
IONS
|
+$27M |
| 3 |
CRZO
Carrizo Oil & Gas Inc
CRZO
|
+$26.1M |
| 4 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
+$23.1M |
| 5 |
F5
FFIV
|
+$21.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$61.1M |
| 2 |
Akamai
AKAM
|
+$34.1M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$25.3M |
| 4 |
Jabil
JBL
|
+$24.7M |
| 5 |
JAH
JARDEN CORPORATION
JAH
|
+$23.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.26% |
| 2 | Industrials | 20.51% |
| 3 | Technology | 13.18% |
| 4 | Financials | 12.29% |
| 5 | Healthcare | 10.79% |
Similar funds
Apex Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Apex Capital Management held 265 positions worth $2.67B, up 17% from $2.28B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Apex Capital Management deployed $114M of net new capital in Q4 2013, opening 38 new positions and adding to 88 existing holdings. Its largest new stake was GNC Holdings, Inc.: 631,387 shares worth $36.9M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Illumina, an estimated $61.1M trimmed.
- Apex Capital Management's largest Q4 2013 buy was GNC Holdings, Inc.: 631,387 shares worth $36.9M.
- Apex Capital Management added most to Carrizo Oil & Gas Inc in Q4 2013, an estimated $26.1M increase.
- Apex Capital Management's biggest Q4 2013 reduction was Illumina, cutting an estimated $61.1M.
- Apex Capital Management fully exited Akamai in Q4 2013, selling an estimated $34.1M.
- Apex Capital Management's ten largest holdings make up 19% of its $2.67B portfolio in Q4 2013.
- Apex Capital Management opened 38 new positions and closed 11 in Q4 2013.
- Apex Capital Management's portfolio value rose 17% quarter-over-quarter to $2.67B.
Based on Apex Capital Management's 13F filing for Q4 2013, filed 14 Jan 2014.